Clinical trials for cellular therapy products: conclusions reached by foreign regulatory bodies
Currently, the problem of adopting viable human cell-based drugs – biomedical cell products (BCPs) – in medical practice in the Russian Federation includes, among others, lack of experience in clinical trials for such drugs and insufficient expert assessment under the national state registration pro...
Saved in:
| Main Authors: | E. V. Melnikova, O. V. Merkulova, V. A. Merkulov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2020-07-01
|
| Series: | Вестник трансплантологии и искусственных органов |
| Subjects: | |
| Online Access: | https://journal.transpl.ru/vtio/article/view/1195 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
World practice of providing scientific advice on the development and authorisation of innovative medicines
by: E. V. Melnikova, et al.
Published: (2021-10-01) -
Current Trends in the Use of Cell Therapy in Regenerative Medicine
by: A. A. Chaplenko, et al.
Published: (2020-06-01) -
International Practices of Registration and Use of Drugs for Gene Therapy in Clinical Practice
by: E. V. Melnikova, et al.
Published: (2020-05-01) -
Treatment of Genetic Diseases: Current Trends in the Development of Biomedical Cell Products
by: O. A. Rachinskaya, et al.
Published: (2019-12-01) -
PRECLINICAL AND CLINICAL ASPECTS OF THE DEVELOPMENT OF BIOMEDICAL CELL PRODUCTS
by: A. V. Tikhomirova, et al.
Published: (2018-03-01)